"Cerebellar Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Primary or metastatic neoplasms of the CEREBELLUM. Tumors in this location frequently present with ATAXIA or signs of INTRACRANIAL HYPERTENSION due to obstruction of the fourth ventricle. Common primary cerebellar tumors include fibrillary ASTROCYTOMA and cerebellar HEMANGIOBLASTOMA. The cerebellum is a relatively common site for tumor metastases from the lung, breast, and other distant organs. (From Okazaki & Scheithauer, Atlas of Neuropathology, 1988, p86 and p141)
Descriptor ID |
D002528
|
MeSH Number(s) |
C04.588.614.250.195.411.211 C10.228.140.211.500.200 C10.228.140.252.200 C10.551.240.250.400.300
|
Concept/Terms |
Cerebellar Neoplasms- Cerebellar Neoplasms
- Cerebellar Tumors
- Cerebellar Tumor
- Tumor, Cerebellar
- Neoplasms, Cerebellar
- Cerebellar Neoplasm
- Neoplasm, Cerebellar
Cerebellar Neoplasms, Primary- Cerebellar Neoplasms, Primary
- Cerebellar Neoplasm, Primary
- Primary Cerebellar Neoplasm
- Primary Cerebellar Neoplasms
- Primary Neoplasms, Cerebellum
- Cerebellum Primary Neoplasm
- Cerebellum Primary Neoplasms
- Neoplasm, Cerebellum Primary
- Primary Neoplasm, Cerebellum
- Neoplasms, Cerebellar, Primary
Benign Cerebellar Neoplasms- Benign Cerebellar Neoplasms
- Benign Cerebellar Neoplasm
- Cerebellar Neoplasm, Benign
- Neoplasm, Benign Cerebellar
- Neoplasms, Cerebellar, Benign
- Cerebellar Neoplasms, Benign
Cerebellar Cancer- Cerebellar Cancer
- Cancer, Cerebellar
- Cerebellar Cancers
- Cerebellar Neoplasms, Malignant
- Neoplasms, Cerebellar, Malignant
- Malignant Cerebellar Neoplasms
- Cerebellar Neoplasm, Malignant
- Malignant Cerebellar Neoplasm
- Neoplasm, Malignant Cerebellar
|
Below are MeSH descriptors whose meaning is more general than "Cerebellar Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Cerebellar Neoplasms".
This graph shows the total number of publications written about "Cerebellar Neoplasms" by people in this website by year, and whether "Cerebellar Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2018 | 2 | 1 | 3 |
2019 | 2 | 0 | 2 |
2020 | 0 | 1 | 1 |
2021 | 2 | 1 | 3 |
2022 | 2 | 0 | 2 |
2023 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cerebellar Neoplasms" by people in Profiles.
-
Tacedinaline (CI-994), a class I HDAC inhibitor, targets intrinsic tumor growth and leptomeningeal dissemination in MYC-driven medulloblastoma while making them susceptible to anti-CD47-induced macrophage phagocytosis via NF-kB-TGM2 driven tumor inflammation. J Immunother Cancer. 2023 01; 11(1).
-
Intratumoral heterogeneity of MYC drives medulloblastoma metastasis and angiogenesis. Neuro Oncol. 2022 09 01; 24(9):1509-1523.
-
The HHIP-AS1 lncRNA promotes tumorigenicity through stabilization of dynein complex 1 in human SHH-driven tumors. Nat Commun. 2022 07 13; 13(1):4061.
-
Circular RNA profiling distinguishes medulloblastoma groups and shows aberrant RMST overexpression in WNT medulloblastoma. Acta Neuropathol. 2021 06; 141(6):975-978.
-
An extracellular vesicle-related gene expression signature identifies high-risk patients in medulloblastoma. Neuro Oncol. 2021 04 12; 23(4):586-598.
-
The Expression of the Cancer-Associated lncRNA Snhg15 Is Modulated by EphrinA5-Induced Signaling. Int J Mol Sci. 2021 Jan 29; 22(3).
-
YBX1 Indirectly Targets Heterochromatin-Repressed Inflammatory Response-Related Apoptosis Genes through Regulating CBX5 mRNA. Int J Mol Sci. 2020 Jun 23; 21(12).
-
Mutated SON putatively causes a cancer syndrome comprising high-risk medulloblastoma combined with caf?-au-lait spots. Fam Cancer. 2019 07; 18(3):353-358.
-
The long noncoding RNA TP73-AS1 promotes tumorigenicity of medulloblastoma cells. Int J Cancer. 2019 12 15; 145(12):3402-3413.
-
Aberrant ERBB4-SRC Signaling as a Hallmark of Group 4 Medulloblastoma Revealed by Integrative Phosphoproteomic Profiling. Cancer Cell. 2018 09 10; 34(3):379-395.e7.